Please enable JavaScript to continue using this application.

Compare $PACB vs $PSNL | Chartloom

Compare

$PACB vs $PSNL

Pacific Biosciences of California Inc · Personalis Inc

PACB

Pacific Biosciences of California Inc

PSNL

Personalis Inc

Compare $PACB vs $PSNL

Comparing Pacific Biosciences of California Inc and Personalis Inc

PACBPacific Biosciences of California Inc

PSNLPersonalis Inc

PACBPacific Biosciences of California Inc

Market cap

$724M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.11x

Rev growth (TTM)

2.0%

YTD performance

26.6%

52W performance

54.3%

FCF yield

-18.1%

PSNLPersonalis Inc

Market cap

$1.71B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

17.58x

Rev growth (TTM)

-13.3%

YTD performance

103.8%

52W performance

84.3%

FCF yield

-5.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PACB

PSNL

Detailed metrics comparison

PACB

Pacific Biosciences of California Inc

PSNL

Personalis Inc

Market Cap

PACB$724M

PSNL$1.71B

Enterprise Value

PACB$1.31B

PSNL$1.61B

Price

PACB$2.33

PSNL$16.00

P/E Ratio

PACBN/A

PSNLN/A

P/S Ratio

PACB4.54x

PSNL24.52x

EV/Sales

PACB8.21x

PSNL23.18x

EV/EBITDA

PACB40.33x

PSNL0.00x

P/B Ratio

PACB333.69x

PSNL7.39x

P/FCF Ratio

PACBN/A

PSNLN/A

EV/FCF

PACB-10.00x

PSNL-15.99x

PEG Ratio

PACBN/A

PSNLN/A

Forward P/E (NTM)

PACBN/A

PSNLN/A

Forward P/S (NTM)

PACB4.11x

PSNL17.58x

Revenue (TTM)

PACB$159M

PSNL$70M

Revenue Growth (YoY)

PACB2.0%

PSNL-13.3%

Forward Rev Growth

PACB15.4%

PSNL37.3%

Gross Margin (TTM)

PACB39.2%

PSNL12.7%

Operating Margin (TTM)

PACB0.0%

PSNL0.0%

EBITDA Margin (TTM)

PACB-88.6%

PSNL-150.1%

Net Margin (TTM)

PACB-82.5%

PSNL-153.8%

FCF Margin (TTM)

PACB-82.0%

PSNL-144.9%

Net Income (TTM)

PACB$-131M

PSNL$-107M

FCF (TTM)

PACB$-131M

PSNL$-101M

EPS (TTM)

PACB-$0.42

PSNL-$1.02

ROE (TTM)

PACB-48845.0%

PSNL-4647.0%

ROA (TTM)

PACB-1684.0%

PSNL-3530.0%

ROIC (TTM)

PACB-1914.0%

PSNL-4601.0%

Cash

PACB$61M

PSNL$94M

Debt

PACB$644M

PSNL$898K

Net Cash/Debt

PACB$-583M

PSNL$93M

Current Ratio (TTM)

PACB4.92x

PSNL5.28x

Quick Ratio (TTM)

PACB3.90x

PSNL4.91x

Debt/Equity (TTM)

PACB272.23x

PSNL0.00x

Debt/Assets (TTM)

PACB0.0%

PSNL0.0%

Interest Coverage (TTM)

PACBN/A

PSNLN/A

Net Debt/EBITDA (TTM)

PACB0.00x

PSNL0.00x

Beta

PACB2.25

PSNL2.37

52W Performance

PACB54.3%

PSNL84.3%

YTD Performance

PACB26.6%

PSNL103.8%

% from 52W High

PACB-32.2%

PSNL-15.3%

% from 52W Low

PACB117.8%

PSNL222.9%

Asset Turnover (TTM)

PACB0.20x

PSNL0.23x

FCF Yield (TTM)

PACB-18.1%

PSNL-5.9%

Earnings Yield (TTM)

PACB-18.2%

PSNL-6.3%

Dividend Yield (TTM)

PACBN/A

PSNLN/A

Rule of 40

PACB-80.0

PSNL-158.2

EV/GP/RG

PACB1.70

PSNL4.29

Ticker research

View PACB research View PSNL research

Metric	PACB Pacific Biosciences of California Inc	PSNL Personalis Inc
Market & Valuation
Market Cap	$724M	$1.71B
Enterprise Value	$1.31B	$1.61B
Price	$2.33	$16.00
P/E Ratio	N/A	N/A
P/S Ratio	4.54x	24.52x
EV/Sales	8.21x	23.18x
EV/EBITDA	40.33x	0.00x
P/B Ratio	333.69x	7.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.00x	-15.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.11x	17.58x
Revenue & Growth
Revenue (TTM)	$159M	$70M
Revenue Growth (YoY)	2.0%	-13.3%
Forward Rev Growth	15.4%	37.3%
Profitability
Gross Margin (TTM)	39.2%	12.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-88.6%	-150.1%
Net Margin (TTM)	-82.5%	-153.8%
FCF Margin (TTM)	-82.0%	-144.9%
Net Income (TTM)	$-131M	$-107M
FCF (TTM)	$-131M	$-101M
EPS (TTM)	-$0.42	-$1.02
ROE (TTM)	-48845.0%	-4647.0%
ROA (TTM)	-1684.0%	-3530.0%
ROIC (TTM)	-1914.0%	-4601.0%
Financial Health
Cash	$61M	$94M
Debt	$644M	$898K
Net Cash/Debt	$-583M	$93M
Current Ratio (TTM)	4.92x	5.28x
Quick Ratio (TTM)	3.90x	4.91x
Debt/Equity (TTM)	272.23x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.25	2.37
52W Performance	54.3%	84.3%
YTD Performance	26.6%	103.8%
% from 52W High	-32.2%	-15.3%
% from 52W Low	117.8%	222.9%
Efficiency & Yields
Asset Turnover (TTM)	0.20x	0.23x
FCF Yield (TTM)	-18.1%	-5.9%
Earnings Yield (TTM)	-18.2%	-6.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-80.0	-158.2
EV/GP/RG	1.70	4.29
Ticker research	View PACB research	View PSNL research

Valuation

P/S Ratio

PACB

4.54x

PSNL

24.52x

EV/FCF

PSNL

-15.99x

PACB

-10.00x

Growth & revenue

Revenue Growth TTM

PACB

2.0%

PSNL

-13.3%

Forward Revenue Growth

PSNL

37.3%

PACB

15.4%

Profitability & performance

Gross Margin

PACB

39.2%

PSNL

12.7%

ROE

PSNL

-4647.0%

PACB

-48845.0%

FCF Yield %

PSNL

-5.9%

PACB

-18.1%

52-Week Performance

PSNL

84.3%

PACB

54.3%

Detailed metrics comparison

PACB

Pacific Biosciences of California Inc

PSNL

Personalis Inc

Market Cap

PACB$724M

PSNL$1.71B

Enterprise Value

PACB$1.31B

PSNL$1.61B

Price

PACB$2.33

PSNL$16.00

P/E Ratio

PACBN/A

PSNLN/A

P/S Ratio

PACB4.54x

PSNL24.52x

EV/Sales

PACB8.21x

PSNL23.18x

EV/EBITDA

PACB40.33x

PSNL0.00x

P/B Ratio

PACB333.69x

PSNL7.39x

P/FCF Ratio

PACBN/A

PSNLN/A

EV/FCF

PACB-10.00x

PSNL-15.99x

PEG Ratio

PACBN/A

PSNLN/A

Forward P/E (NTM)

PACBN/A

PSNLN/A

Forward P/S (NTM)

PACB4.11x

PSNL17.58x

Revenue (TTM)

PACB$159M

PSNL$70M

Revenue Growth (YoY)

PACB2.0%

PSNL-13.3%

Forward Rev Growth

PACB15.4%

PSNL37.3%

Gross Margin (TTM)

PACB39.2%

PSNL12.7%

Operating Margin (TTM)

PACB0.0%

PSNL0.0%

EBITDA Margin (TTM)

PACB-88.6%

PSNL-150.1%

Net Margin (TTM)

PACB-82.5%

PSNL-153.8%

FCF Margin (TTM)

PACB-82.0%

PSNL-144.9%

Net Income (TTM)

PACB$-131M

PSNL$-107M

FCF (TTM)

PACB$-131M

PSNL$-101M

EPS (TTM)

PACB-$0.42

PSNL-$1.02

ROE (TTM)

PACB-48845.0%

PSNL-4647.0%

ROA (TTM)

PACB-1684.0%

PSNL-3530.0%

ROIC (TTM)

PACB-1914.0%

PSNL-4601.0%

Cash

PACB$61M

PSNL$94M

Debt

PACB$644M

PSNL$898K

Net Cash/Debt

PACB$-583M

PSNL$93M

Current Ratio (TTM)

PACB4.92x

PSNL5.28x

Quick Ratio (TTM)

PACB3.90x

PSNL4.91x

Debt/Equity (TTM)

PACB272.23x

PSNL0.00x

Debt/Assets (TTM)

PACB0.0%

PSNL0.0%

Interest Coverage (TTM)

PACBN/A

PSNLN/A

Net Debt/EBITDA (TTM)

PACB0.00x

PSNL0.00x

Beta

PACB2.25

PSNL2.37

52W Performance

PACB54.3%

PSNL84.3%

YTD Performance

PACB26.6%

PSNL103.8%

% from 52W High

PACB-32.2%

PSNL-15.3%

% from 52W Low

PACB117.8%

PSNL222.9%

Asset Turnover (TTM)

PACB0.20x

PSNL0.23x

FCF Yield (TTM)

PACB-18.1%

PSNL-5.9%

Earnings Yield (TTM)

PACB-18.2%

PSNL-6.3%

Dividend Yield (TTM)

PACBN/A

PSNLN/A

Rule of 40

PACB-80.0

PSNL-158.2

EV/GP/RG

PACB1.70

PSNL4.29

Ticker research

View PACB research View PSNL research

Metric	PACB Pacific Biosciences of California Inc	PSNL Personalis Inc
Market & Valuation
Market Cap	$724M	$1.71B
Enterprise Value	$1.31B	$1.61B
Price	$2.33	$16.00
P/E Ratio	N/A	N/A
P/S Ratio	4.54x	24.52x
EV/Sales	8.21x	23.18x
EV/EBITDA	40.33x	0.00x
P/B Ratio	333.69x	7.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.00x	-15.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.11x	17.58x
Revenue & Growth
Revenue (TTM)	$159M	$70M
Revenue Growth (YoY)	2.0%	-13.3%
Forward Rev Growth	15.4%	37.3%
Profitability
Gross Margin (TTM)	39.2%	12.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-88.6%	-150.1%
Net Margin (TTM)	-82.5%	-153.8%
FCF Margin (TTM)	-82.0%	-144.9%
Net Income (TTM)	$-131M	$-107M
FCF (TTM)	$-131M	$-101M
EPS (TTM)	-$0.42	-$1.02
ROE (TTM)	-48845.0%	-4647.0%
ROA (TTM)	-1684.0%	-3530.0%
ROIC (TTM)	-1914.0%	-4601.0%
Financial Health
Cash	$61M	$94M
Debt	$644M	$898K
Net Cash/Debt	$-583M	$93M
Current Ratio (TTM)	4.92x	5.28x
Quick Ratio (TTM)	3.90x	4.91x
Debt/Equity (TTM)	272.23x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.25	2.37
52W Performance	54.3%	84.3%
YTD Performance	26.6%	103.8%
% from 52W High	-32.2%	-15.3%
% from 52W Low	117.8%	222.9%
Efficiency & Yields
Asset Turnover (TTM)	0.20x	0.23x
FCF Yield (TTM)	-18.1%	-5.9%
Earnings Yield (TTM)	-18.2%	-6.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-80.0	-158.2
EV/GP/RG	1.70	4.29
Ticker research	View PACB research	View PSNL research